Provided by Tiger Fintech (Singapore) Pte. Ltd.

Exact Sciences

44.15
+1.052.44%
Post-market: 44.880.7300+1.65%19:17 EDT
Volume:2.03M
Turnover:89.42M
Market Cap:8.20B
PE:-7.90
High:44.49
Open:43.30
Low:42.56
Close:43.10
Loading ...

Exact Sciences Corp : Leerink Partners Cuts Target Price to $85 From $95

THOMSON REUTERS
·
20 Feb

Exact Sciences price target lowered to $65 from $70 at Barclays

TIPRANKS
·
20 Feb

Barclays Keeps Their Buy Rating on Exact Sciences (EXAS)

TIPRANKS
·
20 Feb

U.S. RESEARCH ROUNDUP-Analog Devices, Celanese, Etsy

Reuters
·
20 Feb

Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
20 Feb

Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript

Motley Fool Transcribing
·
20 Feb

Exact Sciences Corp : Jefferies Cuts Target Price to $80 From $85

THOMSON REUTERS
·
20 Feb

Exact Sciences Reports Strong Revenue Growth in 2024

TIPRANKS
·
20 Feb

Exact Sciences Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Feb

BRIEF-Exact Sciences Corp Plans To Launch Three New Cancer Tests In 2025

Reuters
·
20 Feb

Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
20 Feb

Exact Sciences Stock Slides On Q4 Earnings: The Details

Benzinga
·
20 Feb

Exact Sciences: Q4 Earnings Snapshot

Associated Press Finance
·
20 Feb

Exact Sciences Corp: Plans to Launch Three New Cancer Tests in 2025

THOMSON REUTERS
·
20 Feb

Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue

StockStory
·
20 Feb

Exact Sciences Q4 Net Loss Widens, Revenue Up; Sets Outlook

MT Newswires Live
·
20 Feb

Exact Sciences reports Q4 EPS ($4.67), consensus (19c)

TIPRANKS
·
20 Feb

Exact Sciences says plans to launch three new cancer tests in 2025

TIPRANKS
·
20 Feb

Exact Sciences sees FY25 revenue $3.025B-$3.085B, consensus $3.06B

TIPRANKS
·
20 Feb

Exact Sciences Corp - FY 2025 Revenue Guidance of $3.025-$3.085 Billion

THOMSON REUTERS
·
20 Feb